You are here

CART-ddBCMA

Gilead’s Kite Expands Arcellx Pact with $285M Equity Investment, Upfront Cash

BioSpace

Wed, 11/15/23 - 11:11 am

Gilead Sciences

FDA places clinical hold on Arcellx’s multiple myeloma therapy trial

Clinical Trials Arena

Tue, 06/20/23 - 09:57 am

relapsed or refractory multiple myeloma

clinical trials